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The pathological increase in the levels of reactive oxygen species (ROS) in the retinal pigment epithelium
(RPE), is implicated in the development of age-related macular degeneration (AMD). The discovery of
drug candidates to effectively protect RPE cells from oxidative damage is required to resolve the pa-
thological aspects and modify the process of AMD. In this study, a FDA-approved anti-malaria drug,
Artemisinin was found to suppress hydrogen peroxide (H2O2)-induced cell death in human RPE cell-
D407 cells. Further study showed that Artemisinin signiﬁcantly suppressed H2O2 induced D407 cell
death by restoring abnormal changes in nuclear morphology, intracellular ROS, mitochondrial membrane
potential and apoptotic biomarkers. Western blotting analysis showed that Artemisinin was able to ac-
tivate extracellular regulated ERK/CREB survival signaling. Furthermore, Artemisinin failed to suppress
H2O2-induced cytotoxicity and the increase of caspase 3/7 activity in the presence of the ERK inhibitor
PD98059. Taken together, these results suggest that Artemisinin is a potential protectant with the pro-
survival effects against H2O2 insult through activation of the ERK/CREB pathway.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Age-related macular degeneration (AMD) is a progressive de-
generative eye disorder which is mainly caused by a breakdown of
the macula in the retina. At early stage of AMD, it does not lead to
any symptoms or vision loss. However, late AMD seriously affects
vision and further inﬂuences daily activities such as driving, reading,
face recognition and life quality [1]. In the developed world, AMD is
the common leading cause of blindness and its incidence keeps in-
creasing in the people with age 65 or older [2]. AMD can be divided
into two types: dry AMD 85–90%) and wet AMD 10–15%). At present,
the current therapies such as laser photocoagulation, photodynamic
therapy and anti-VEGF therapy are limited to wet AMD, but the
more prevalent dry AMD still lacks effective therapies [3,4].
The clinical characteristic of dry AMD is a decrease in chorior-
etinal blood ﬂow [5]. Chorioretinal atrophy results in subsequent
degeneration of retinal pigment epithelium (RPE) cells. The RPE, a
pigmented monolayer, plays a critical role in maintaining retinal
functions such as nutrient transport, formation of the outer blood
retinal barrier to block the passage of water and ions, the phago-
cytosis of photoreceptor outer segment tips as well as theB.V. This is an open access article u
ng).regeneration of visual pigments etc [6–8]. Age-associated degen-
eration of RPE eventually lead to loss of photoreceptor cells and
vision loss in the affected area [9]. Thus, the identiﬁcation of ef-
fective drug candidates to protect RPE cells from death may be a
potential strategy for reducing the process of dry AMD.
Although the etiology and pathogenesis of dry AMD are not fully
elucidated, age-related alterations such as increased oxidative stress
and decreased cell density in the RPE were considered as main
changes in dry AMD [10–15]. The adequate oxygen distribution and
supply are necessary for maintenance of retinal function [16]. Due to
high-oxygen microenvironment in the retina, RPE cells are exposed
to constant oxidative stress resulting from reactive oxygen species
(ROS) caused by intense light exposure [17]. Light-induced retinal
damage leads to the increase of ROS such as superoxide radical
( O2), hydroxyl radical ( OH) and hydrogen peroxide (H2O2). High
levels of ROS damage the RPE cells, which have been linked with the
pathogenesis of clinical visual diseases [17]. H2O2 is an oxidizing
agent, commonly used to cause irreversible oxidative damage and
activation of the apoptotic cascade in various RPE cell models [18,19].
Therefore, H2O2-induced oxidative injury in RPE cell model, is sui-
table for investigating the effects of drug candidates for the treat-
ment of dry AMD.
Recently, we perform H2O2-induced RPE cell injury model to
identify potential protective candidates from various Chinese
medicine. Artemisinin (the chemical structure is shown in Fig. 1A),nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Protective effects of Artemisinin against H2O2-induced cytotoxicity in D407 cells. (A) The structure of Artemisinin. (B) Cells were treated with Artemisinin (3–100 mM)
or 0.1% DMSO (vehicle control) for 24 h and cell viability was measured using the MTT assay. Cells were pre-treated with Artemisinin at indicated concentration or 0.1%
DMSO (vehicle control) for 2 h and then incubated with or without 100 mM H2O2 for a further 24 h. Cell viability and the release of LDH were measured by MTT assay (C) and
LDH assay (D), respectively. (E) Apoptosis of D407 cells was detected by staining with Hoechst 33342 and visualized by ﬂuorescence microscopy. The number of apoptotic
nuclei with condensed chromatin was counted from the photomicrographs and presented as a percentage of the total number of nuclei. #Po0.05, ###Po0.005 versus
control group;**Po0.01,***Po0.005 versus the H2O2-treated group were considered statistically signiﬁcant differences.
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protective effect against H2O2-induced oxidative injury in the
D407 (a human RPE cell line) cells. Artemisinin, a sesquiterpene
lactone, was originally isolated from the qinghao (the Chinese
name of plant Artemisia annua L.) by Chinese scientists [20]. At
present, Artemisinin and its derivatives have been clinically used
to treat malaria in the world with great safety. Accumulated stu-
dies indicate that Artemisinin and its derivatives have additional
potential in anti-Inﬂammation [21], immune-regulation [22], anti-
viruses [23] and anti-cancer [24]. In the present study, we found
that the protective effect of Artemisinin against H2O2-induced
oxidative damage in RPE cells was via restoring abnormal changes
in nuclear morphology, intracellular ROS, mitochondrial mem-
brane potential and caspase activation. We also investigated the
roles of the ERK1/2 survival pathway in the protective effect of
Artemisinin.2. Materials and methods
2.1. Materials
3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bro-
mide (MTT), CellROXs Deep Red Reagent, 5,5′,6,6′-tetrachloro-
1,1′,3,3′-tetraethyl-benzimidazolyl-carbocyanineiodide (JC-1), and
Hoechst 33342 were purchased from Molecular Probes (Eugene,
OR, USA). DMSO is from Sigma (Sigma, US). Horseradish perox-
idase-conjugated anti-rabbi, anti-beta-actin, anti-phospho-CREB,
anti-CREB, anti-phospho-Akt, anti-Akt, anti-phospho-ERK1/2 and
anti-ERK1/2 were purchased from Cell Signaling Technology(Woburn, USA). PD98059 and LY294002 were obtained from
Merck Millipore. Super Signal West Pico chemiluminescent sub-
strate was purchased from Thermo Scientiﬁc (Rockford, IL, USA).
Gibcos fetal bovine serum (FBS) and penicillin-streptomycin (PS)
were purchased from Life Technologies (Grand Island, NY, USA).
2.2. Cell culture
Human retinal pigment epithelial cell line D407 was obtained
from cell bank, Sun Yat-sen University (Guangzhou, China). Cell
passages 5–10 were used for all experiments and cell cultures were
maintained in 75-cm2 tissue culture ﬂasks in DMEM supple-
mented with 10% FBS, streptomycin 100 μg/ml, penicillin 100 U/
ml, and incubated at 37 °C with 5% CO2 humidiﬁed atmosphere.
The medium was replaced every 2 days, and cells were sub-cul-
tured by trypsin treatment twice a week, at a 1:5 split ratio.
2.3. MTT assay
Cell viability was determined by MTT assay with a slight
modiﬁcation of the protocol described by Zheng and Quirion [25].
Brieﬂy, D407 cells were seeded in 96-well plates at a density of
2104 cells/well. After serum starvation, the cultures were ex-
posed to reagents for 24 h. Thereafter, the cells were incubated
with MTT (0.5 mg/ml) for an additional 3 h. The medium was as-
pirated from each well and DMSO (100 mL) was added. Absorbance
at 570 nm was measured by Inﬁnite M200 PRO Multimode Mi-
croplate (Tecan, Switzerland). Cell viability was presented as a
percentage compared with the control group.
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Cell cytotoxicity was determined by measuring the activity of
lactate dehydrogenase (LDH) released into the incubation medium
when cellular membranes were damaged. D407 cells were seeded
into 96-well plates (5103 cells/well). After appropriate treat-
ment, the activity of released LDH in the medium was determined
according to the instructions of CytoTox-ONE™ Homogeneous
Membrane Integrity Assay (Promega, USA). The ﬂuorescent in-
tensity was measured using Inﬁnite M200 PRO Multimode Mi-
croplate at an excitation wavelength of 560 nm and emission at
590 nm. All values of % LDH released were normalized to the
control group.
2.5. Hoechst 33342 staining
D407 cells were seeded into 12-well plates (8104 cells/well).
After appropriate treatment, these cells were washed with PBS,
ﬁxed with 4% formaldehyde (v/v in PBS) and then stained with
10 μg/ml Hoechst 33342 for 15 min at room temperature. After
washing with PBS, the nuclei were visualized using EVOS FL
Imaging System (Thermo Fisher Scientiﬁc, USA).
2.6. Measurement of intracellular ROS levels
Intracellular ROS generation was evaluated using CellROXs
Deep Red Reagent (Thermo Fisher Scientiﬁc, USA). The cells were
incubated with CellROXs Deep Red Reagent (5 mM) in DMEM for
1 h in the dark, rinsed twice with 1x PBS solution and the ﬂuor-
escence was observed and recorded using a ﬂuorescent micro-
scope at an excitation wavelength of 640 nm and an emission
wavelength of 665 nm. Semi-quantiﬁcation of ROS level was as-
sessed by using Image-J software. All values of % ROS level were
normalized to the control group.
2.7. Measurement of mitochondrial membrane potential (△ψm)
JC-1 dye was used to monitor mitochondrial integrity. In brief,
D407 cells were seeded into black 96-well plates (1104 cells/
well). After appropriate treatment, the cells were incubated with
JC-1 (10 μg/ml in medium) at 37 °C for 15 min and then washed
twice with PBS. For signal quantiﬁcation, the intensity of red
ﬂuorescence (excitation 560 nm, emission 595 nm) and green
ﬂuorescence (excitation 485 nm, emission 535 nm) were mea-
sured using a Inﬁnite M200 PRO Multimode Microplate. Mi-
tochondrial membrane potential (△ψm) was calculated as the ratio
of JC-1 red/green ﬂuorescence intensity and the value was nor-
malized to the control group. The ﬂuorescent signal in the cells
was also observed and recorded with a ﬂuorescent microscope.3. Caspase 3/7 activity assay
After treatment, the activity of caspase 3/7 was measured using
the commercially available Caspase-Glos 3/7 Assay (Invitrogen,
USA) according to the manufacturer's protocol. Brieﬂy, D407 cells
were lysed in lysis buffer and centrifuged at 12,500 g for 5 min
15 mL of cell lysate was incubated with 50 mL of 2X substrate
working solution at room temperature for 30 min in 96-well
plates. The ﬂuorescence intensity was then determined by Inﬁnite
M200 PRO Multimode Microplate at an excitation wavelength of
490 nm and emission at 520 nm. The ﬂuorescence intensity of
each sample was normalized to the protein concentration of
sample. All values of % caspase 3/7 activities were normalized to
the control group.3.1. Western blotting
Western blotting was performed as previously described [25].
Brieﬂy, treated cells from different experimental conditions were
rinsed once with ice-cold PBS and lysed in RIPA buffer [50 mM
Tris–HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Igepal CA-630, 1%
sodium dodecyl sulfate (SDS), 50 mM NaF, 1 mM NaVO3, 5 mM
phenylmethysulfonyl ﬂuoride, 10 μg/ml leupeptin (Sigma), and
50 μg/ml aprotinin (Sigma) or 2 sample buffer (ﬁnal con-
centration of 62.5 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 10% glycerol,
50 mM dithiothreitol, and 0.1% (w/v) bromophenol blue)]. Samples
with equal amounts of protein determined with a BCA protein
assay kit according to the manufacturer’s instructions, were se-
parated by SDS polyacrylamide gel electrophoresis (PAGE) and
transferred to PVDF membranes. The phosphorylation of Akt and
ERK1/2 was determined by Western blotting with their respective
phospho-speciﬁc antibodies while β-actin was using as a total
protein control. Blot was visualized using ECL kit according to the
manufacturer's instructions. The blots were stripped, and reprobed
with anti-Akt or anti-ERK1/2, respectively. The intensity of the
bands was quantiﬁed using ImageJ software.
3.2. Statistical analysis
Statistical analysis was performed using GraphPad Prism
5.0 statistical software (GraphPad software, Inc., San Diego, CA,
USA). All experiments were performed in triplicate. Data are ex-
pressed as mean7standard deviation (SD). Statistical analysis was
carried out using one-way ANOVA followed by Tukey's multiple
comparison, with po0.05 considered statistically signiﬁcant.4. Results
4.1. Artemisinin attenuated H2O2-induced D407 cell death
To evaluate the cytotoxicity of Artemisinin, D407 cells were
incubated with various concentrations of Artemisinin for 24 h and
the cytotoxicity was determined by MTT assay. As shown in Fig. 1B,
Artemisinin at between 3 and 30 μM did not cause any cytotoxi-
city in D407 cells compared to the control group, and was used in
further experiments. To test the protective effects of Artemisinin,
D407 cells were treated with Artemisinin for 2 h before being
exposed to H2O2 for 24 h. The result of MTT assay showed that the
treatment of 100 μM H2O2 resulted in dominant cell death (50%),
whereas pre-treatment with 3, 10 and 30 μM of Artemisinin sig-
niﬁcantly attenuated H2O2-induced cell death in a concentration-
dependent manner (54%, 65% and 75%, respectively) (Fig. 1C). The
protective activity of Artemisinin was also conﬁrmed by the lactate
dehydrogenase (LDH) assay. As shown in Fig. 1D, pre-treated cells
with 30 μM of Artemisinin for 2 h signiﬁcantly reduced H2O2-in-
duced LDH leakage (from 251% to 199%). Nuclei condensation was
observed in D407 cells after exposure to 100 μM H2O2 (26%) in
Hoechst 33342 staining assay. However, a pre-treatment of 30 μM
Artemisinin decreased these changes (9%) (Fig. 1E). Artemisinin
alone did not lead to nuclear morphological change of D407 cells.
4.2. Artemisinin decreased H2O2-induced change of mitochondrial
membrane potential and caspase 3/7 activity
Mitochondrial inhibition causes the loss of mitochondrial
membrane potential (△ψm). To determine whether Artemisinin
could reduce H2O2-induced △ψm loss, the △ψm in D407 cells was
assessed by analyzing the red/green ﬂuorescent intensity ratio of
JC-1 staining. Exposure of D407 cells to 100 μM H2O2 resulted in
an increase in green ﬂuorescence intensity indicating △ψm
Fig. 2. Artemisinin attenuated H2O2-induced mitochondrial membrane potential (△ψm) loss and caspase 3/7 activity increase in D407 cells. After pre-treatment with 30 μM
Artemisinin or 0.1% DMSO (vehicle control) for 2 h, D407 cells were incubated with or without 100 μM H2O2 for another 24 h. (A) △ψm was determined by the JC-1 assay.
(B) Quantiﬁcation of caspase 3/7 activity was determined by caspase 3/7 activity assay. ###Po0.005 versus control group;***Po0.005 versus H2O2-treated group was
considered signiﬁcantly different.
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30 μM for 2 h attenuated H2O2-induced △ψm loss (88%).
Caspase 3/7 is a main biomarker in the apoptosis of dopami-
nergic neuronal cells. As shown in Fig. 2B, treatment of cells with
100 μM H2O2 for 24 h increased caspase 3/7 activity by more than
2-fold compared to the control group (219%). In contrast, pre-
treatment with Artemisinin signiﬁcantly reduced caspase 3/7 ac-
tivation induced by H2O2 (160%).
4.3. Artemisinin suppressed H2O2-induced increase of intracellular ROS
The accumulation of excess ROS is considered to be one of the
main causes of cell damage induced by H2O2. Intracellular ROSFig. 3. Artemisinin reduced the increase of H2O2-induced oxidative stress in D407 cells.
D407 cells were incubated with or without 100 μM H2O2 for another 24 h. Intracellular
control group;***Po0.005 versus H2O2-treated group was considered signiﬁcantly diffewere measured by staining with a ﬂuorescent probe, CellROXs
Deep Red Reagent, in D407 cells. As shown in Fig. 3, 100 μM H2O2
caused a signiﬁcant increase in ﬂuorescent intensity in the cells
compared to the control group (177%). However, the increase in
ROS was signiﬁcantly suppressed by pretreatment with Artemisi-
nin at 30 μM (126%).
4.4. Artemisinin up-regulated ERK/CREB signaling
Previous studies indicated that Artemisinin was able to activate
ERK signaling in various cell models [26–28]. ERK was found to be
involved in the inhibition of apoptosis. To determine whether the
ERK signaling pathway is regulated by Artemisinin in D407 cells,After pre-treatment with 30 μM Artemisinin or 0.1% DMSO (vehicle control) for 2 h,
ROS level was determined by the CellROXs Deep Red Reagent. ###Po0.005 versus
rent.
Fig. 4. Involvement of ERK/CREB signaling in the cytoprotective effect of Artemisinin. (A) D407 cells were pre-treated with 30 mM Artemisinin. The cells were collected at 0,
30, 60, and 120 min. The expression of phosphorylated ERK1/2, total ERK1/2, phosphorylated Akt, total Akt and phosphorylated CREB, total CREB and beta-actin were
detected by Western blotting with speciﬁc antibodies (A). (B)(C)(D) Quantiﬁcation of representative protein band from Western blotting. **Po0.01,***P o0.005 versus the
0 min group was considered signiﬁcantly different.
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2 h and then the phosphorylation of ERK1/2 (Thr202/Tyr204) was
examined by Western blot analysis. As shown in Fig. 4A and B,
Artemisinin gradually increased the phosphorylation intensity of
ERK1/2 in D407 cells within 2 h. These results suggested that ERK
survival signaling could be activated by Artemisinin. In contrast,
Artemisinin had no effect on the phosphorylation of AKT, a serine/
threonine kinase implicated in cell survival (Fig. 4A and C). CREB is
an ERK-mediated nuclear transcription factor involved in many
biological functions including neuronal survival. The results of
Western blotting showed that the phosphorylation of CREB
(Ser133) was increased signiﬁcantly by Artemisinin (Fig. 4D).
4.5. ERK signaling was involved in the protective effect of Artemisinin
To further conﬁrm the involvement of ERK signaling in the
protective effects of Artemisinin, the ERK pathway inhibitorFig. 5. The ERK pathway inhibitor PD98059 attenuated the protective effects of Artemisin
and then incubated with or without H2O2 for a further 24 h. Cell viability and caspase
###Po0.005 versus control group;*Po0.05,**Po0.01 versus the ArtemisininþH2O2-trePD98059 was used in cell survival assay with H2O2 cytotoxicity. As
shown in Fig. 5A, the protective effect of Artemisinin was abol-
ished by the application of PD98059 in MTT assay. Similar results
were obtained from caspase 3/7 assay which showed that Arte-
misinin failed to suppress the increase of caspase 3/7 activity in
the presence of the ERK pathway inhibitor (Fig. 5B), suggesting
that ERK signaling is involved in the protective effects of
Artemisinin.5. Discussion
Oxidative stress in the retina plays a critical role in the pa-
thogenesis of dry AMD. Although antioxidant defense mechanisms
in retinal cells are sufﬁcient to counteract weak oxidative stress,
strong oxidative stress disrupt normal antioxidant mechanisms
and result in irreversible damage to the retina. Using additionalin. D407 cells were pre-treated with 30 mM Artemisinin and 25 mM PD98059 for 2 h
3/7 activity were measured by MTT assay (A) and caspase 3/7 activity assay (B).
ated group was considered signiﬁcantly different.
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dative damage and maintain the function of retina. Yttrium oxide
nanoparticles are excellent free radical scavengers prevent pho-
toreceptor death in a light-damage model of retinal degeneration
[29]. In addition, experimental and clinical studies suggest that
taking high dose of antioxidant vitamins and zinc supplements are
potential strategies for delaying the progression of AMD and vision
loss [30]. In this study, we found that 100 mM H2O2 resulted in the
collapse of the △ψm and increase of ROS in RPE cells while pre-
treatment of Artemisinin was able to signiﬁcantly suppress these
abnormal changes in D407 RPE cells. Apoptosis is a frequent type
of cell death observed in RPE cells [31]. The decrease of cell via-
bility, the increase of LDH release and nuclear morphological
changes induced by H2O2 were signiﬁcantly suppressed by Arte-
misinin (Fig. 1), suggesting that anti-oxidant activity of Artemisi-
nin contributes to its protective effects. The concentration range of
artemisinin (10–30 mM) used in our experiments has no toxicity in
D407 cells and is therapeutically relevant based on the in vitro
quantitation with malaria plasmodion indicate that Atemisinin is a
safe protectant [43].
Increased mitochondrial DNA damage and protein loss of
election transport chain in RPE cells have been found in AMD
patients, suggesting that mitochondrial dysfunction plays a key
role in the process of AMD [32–35]. Mitochondrial apoptotic
pathway due to mitochondria deﬁciency plays a critical role in the
pathogenesis of retinal diseases. It has been reported that strate-
gies to block mitochondrial apoptotic pathway are potential ther-
apeutics to prevent retinal pigment epithelial cells death. In this
study, our results showed that H2O2-induced △ψm loss could be
suppressed by pre-treatment with Artemisinin. The increase of
intracellular ROS induced by H2O2, leads to damage to the mi-
tochondrial membrane and results in the collapse of the △ψm and
activation of the apoptotic cascade [36–39]. Pre-treatment with
Artemisinin was able to suppress the activation of caspase 3/7
(Fig. 3).
ERK/CREB pathway is a central signaling component that plays
a role in the initiation and regulation of most of the stimulated
cellular processes such as proliferation, survival and differentiation
[40]. Both AKT and ERK survival pathways are reported as a key
signaling to induce CREB phosphorylation and cellular anti-oxi-
dant mechanism [41,42]. In our study, the increase in CREB
phosphorylation, following treatment with Artemisinin, was ob-
served. However, it was noted that ERK, no AKT, could be activatedFig. 6. The possible mechanism of Artemisinin.by Artemisinin. Furthermore, our results showed that Artemisinin
failed to suppress H2O2-induced cytotoxicity and the increase of
caspase 3/7 activity in the presence of the ERK inhibitor PD98059
(Fig. 5). Therefore, these results provide mechanistic evidence to
support the notion that Artemisinin-regulated protective effects
against H2O2-induced oxidative stress occur via ERK dependent
CREB activation.
In summary, our ﬁndings demonstrate that Artemisinin is able
to reduce H2O2-induced oxidative stress in D407 retinal pigment
epithelial cells through the regulation of multiple mechanisms
including (1) inhibiting the generation of intracellular ROS;
(2) modulating △ψm and caspase 3/7 dependent pathway; (3) ac-
tivating ERK1/2 signaling (Fig. 6). The protective effects of Arte-
misinin to attenuate H2O2-mediated intrinsic mitochondrial
apoptotic pathway are, at least in part, mediated via the activation
of ERK1/2 signaling. Our results offer support for the potential
development of Artemisinin to prevent retinal pigment epithelial
cells death in the process of AMD.Acknowledgements
This research was ﬁnancially supported by the Guangdong
Provincial Project of Science and Technology (2011B050200005),
the National Natural Science Foundation of China (31371088),
SRG2015-00004-FHS and MYRG2016–00052-FHS from University
of Macau, and the Science and Technology Development Fund
(FDCT) of Macao (FDCT 021/2015/A1).References
[1] A.L. Coleman, F. Yu, K.E. Ensrud, K.L. Stone, J.A. Cauley, K.L. Pedula, M.
C. Hochberg, C.M. Mangione, Impact of age-related macular degeneration on
vision-speciﬁc quality of life: follow-up from the 10-year and 15-year visits of
the study of osteoporotic fractures, Am. J. Ophthalmol. 150 (2010) 683–691.
[2] S. Resnikoff, I. Kocur, D.E. Etya’ale, T.O. Ukety, Vision 2020 – the right to sight,
Ann. Trop. Med. Parasitol. 102 (Suppl 1) (2008) S3–S5.
[3] A. Lux, H. Llacer, F.M. Heussen, A.M. Joussen, Non-responders to bevacizumab
(Avastin) therapy of choroidal neovascular lesions, Br. J. Ophthalmol. 91 (2007)
1318–1322.
[4] J. Ambati, B.K. Ambati, S.H. Yoo, S. Ianchulev, A.P. Adamis, Age-related macular
degeneration: etiology, pathogenesis, and therapeutic strategies, Surv. Oph-
thalmol. 48 (2003) 257–293.
[5] J.E. Grunwald, S.M. Hariprasad, J. DuPont, M.G. Maguire, S.L. Fine, A.J. Brucker,
A.M. Maguire, A.C. Ho, Foveolar choroidal blood ﬂow in age-related macular
degeneration, Invest. Ophthalmol. Vis. Sci. 39 (1998) 385–390.
[6] O. Strauss, The retinal pigment epithelium in visual function, Physiol. Rev. 85
(2005) 845–881.
[7] D. Bok, The retinal pigment epithelium: a versatile partner in vision, J. Cell Sci.
Suppl. 17 (1993) 189–195.
[8] D. Bok, Processing and transport of retinoids by the retinal pigment epithe-
lium, Eye 4 (Pt 2) (1990) 326–332.
[9] C.A. Curcio, P.L. Saunders, P.W. Younger, G. Malek, Peripapillary chorioretinal
atrophy: Bruch’s membrane changes and photoreceptor loss, Ophthalmology
107 (2000) 334–343.
[10] R. Klein, Overview of progress in the epidemiology of age-related macular
degeneration, Ophthalmic Epidemiol. 14 (2007) 184–187.
[11] S.J. McGimpsey, U. Chakravarthy, VEGF-targeted therapy and beyond: phar-
macotherapy and emerging Treatments in agerelated macular degeneration,
Expert Rev. Clin. Pharmacol. 3 (2010) 243–252.
[12] X. Ding, M. Patel, C.C. Chan, Molecular pathology of age-related macular de-
generation, Progress. Retin. Eye Res. 28 (2009) 1–18.
[13] P. Tokarz, K. Kaarniranta, J. Blasiak, Role of antioxidant enzymes and small
molecular weight antioxidants in the pathogenesis of age-related macular
degeneration (AMD), Biogerontology 14 (2013) 461–482.
[14] R.N. Mitra, S.M. Conley, M.I. Naash, Therapeutic approach of nanotechnology
for oxidative stress induced ocular neurodegenerative diseases, Adv. Exp. Med.
Biol. 854 (2016) 463–469.
[15] Y.Z. Fang, S. Yang, G. Wu, Free radicals, antioxidants, and nutrition, Nutrition
18 (2002) 872–879.
[16] D.Y. Yu, S.J. Cringle, Oxygen distribution and consumption within the retina in
vascularised and avascular retinas and in animal models of retinal disease,
Progress Retin. Eye Res. 20 (2001) 175–208.
[17] D.T. Organisciak, D.K. Vaughan, Retinal light damage: mechanisms and pro-
tection, Progress Retin. Eye Res. 29 (2010) 113–134.
C.-M. Chong, W. Zheng / Redox Biology 9 (2016) 50–5656[18] M.H. Kim, J. Chung, J.W. Yang, S.M. Chung, N.H. Kwag, J.S. Yoo, Hydrogen
peroxide-induced cell death in a human retinal pigment epithelial cell line,
ARPE-19, Korean J. Ophthalmol. 17 (2003) 19–28.
[19] L. Lu, S.F. Hackett, A. Mincey, H. Lai, P.A. Campochiaro, Effects of different types
of oxidative stress in RPE cells, J. Cell. Physiol. 206 (2006) 119–125.
[20] Y. Tu, The discovery of artemisinin (qinghaosu) and gifts from Chinese med-
icine, Nat. Med. 17 (2011) 1217–1220.
[21] C. Shi, H. Li, Y. Yang, L. Hou, Anti-inﬂammatory and immunoregulatory func-
tions of artemisinin and its derivatives, Mediat. Inﬂamm. 2015 (2015) 435713.
[22] C. Cheng, W.E. Ho, F.Y. Goh, S.P. Guan, L.R. Kong, W.Q. Lai, B.P. Leung, W.
S. Wong, Anti-malarial drug artesunate attenuates experimental allergic
asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway, PLoS
One 6 (2011) e20932.
[23] T. Efferth, M.R. Romero, D.G. Wolf, T. Stamminger, J.J. Marin, M. Marschall, The
antiviral activities of artemisinin and artesunate, Clin. Infect. Dis. 47 (2008)
804–811.
[24] A.K. Das, Anticancer effect of antimalarial artemisinin compounds, Ann. Med.
Health Sci. Res. 5 (2015) 93–102.
[25] W.H. Zheng, R. Quirion, Glutamate acting on N-methyl-D-aspartate receptors
attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and
its survival signaling properties in rat hippocampal neurons, J. Biol. Chem. 284
(2009) 855–861.
[26] W. Zheng, C.M. Chong, H. Wang, X. Zhou, L. Zhang, R. Wang, Q. Meng, P. La-
zarovici, J. Fang, Artemisinin conferred ERK mediated neuroprotection to PC12
cells and cortical neurons exposed to sodium nitroprusside-induced oxidative
insult. Free Radic. Biol. Med., 2016.
[27] Sarina, Y. Yagi, O. Nakano, T. Hashimoto, K. Kimura, Y. Asakawa, M. Zhong,
S. Narimatsu, E. Gohda, Induction of neurite outgrowth in PC12 cells by ar-
temisinin through activation of ERK and p38 MAPK signaling pathways, Brain
Res. 1490 (2013) 61–71.
[28] S.H. Kim, S.Y. Chun, T.S. Kim, Interferon-alpha enhances artemisinin-induced
differentiation of HL-60 leukemia cells via a PKC alpha/ERK pathway, Eur. J.
Pharmacol. 587 (2008) 65–72.
[29] R.N. Mitra, M.J. Merwin, Z. Han, S.M. Conley, M.R. Al-Ubaidi, M.I. Naash, Yt-
trium oxide nanoparticles prevent photoreceptor death in a light-damage
model of retinal degeneration, Free Radic. Biol. Med. 75 (2014) 140–148.
[30] Age-Related Eye Disease Study Research, G. A randomized, placebo-controlled,
clinical trial of high-dose supplementation with vitamins C and E, beta car-
otene, and zinc for age-related macular degeneration and vision loss: AREDS
report no. 8. Arch. Ophthalmol., vol. 119, 2001, pp. 1417–1436.
[31] E. Kucuksayan, E.K. Konuk, N. Demir, B. Mutus, M. Aslan, Neutralsphingomyelinase inhibition decreases ER stress-mediated apoptosis and in-
ducible nitric oxide synthase in retinal pigment epithelial cells, Free Radic.
Biol. Med. 72 (2014) 113–123.
[32] H. Lin, H. Xu, F.Q. Liang, H. Liang, P. Gupta, A.N. Havey, M.E. Boulton, B.
F. Godley, D.N.A. Mitochondrial, damage and repair in RPE associated with
aging and age-related macular degeneration, Invest. Ophthalmol. Vis. Sci. 52
(2011) 3521–3529.
[33] P.P. Karunadharma, C.L. Nordgaard, T.W. Olsen, D.A. Ferrington, D.N.
A. Mitochondrial, damage as a potential mechanism for age-related macular
degeneration, Invest. Ophthalmol. Vis. Sci. 51 (2010) 5470–5479.
[34] M.R. Terluk, R.J. Kapphahn, L.M. Soukup, H. Gong, C. Gallardo, S.R. Montezuma,
D.A. Ferrington, Investigating mitochondria as a target for treating age-related
macular degeneration, J. Neurosci. 35 (2015) 7304–7311.
[35] C.L. Nordgaard, P.P. Karunadharma, X. Feng, T.W. Olsen, D.A. Ferrington, Mi-
tochondrial proteomics of the retinal pigment epithelium at progressive
stages of age-related macular degeneration, Invest. Ophthalmol. Vis. Sci. 49
(2008) 2848–2855.
[36] P. Nicotera, Caspase requirement for neuronal apoptosis and neurodegenera-
tion, IUBMB Life 49 (2000) 421–425.
[37] M.T. Lin, M.F. Beal, Mitochondrial dysfunction and oxidative stress in neuro-
degenerative diseases, Nature 443 (2006) 787–795.
[38] G.S. Salvesen, Caspases: opening the boxes and interpreting the arrows, Cell
Death Differ. 9 (2002) 3–5.
[39] F.W. Sunderman, The Chloride and Nitrogen Balances and Weight Changes in
Pneumonia, University Of Pennsylvania, Philadelphia 1929, pp. 313–332.
[40] M. Hytti, N. Piippo, A. Salminen, P. Honkakoski, K. Kaarniranta, A. Kauppinen,
Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inﬂamma-
tion in ARPE-19 cells, Exp. Eye Res. 132 (2015) 208–215.
[41] C.M. Chong, Z.Y. Zhou, V. Razmovski-Naumovski, G.Z. Cui, L.Q. Zhang, F. Sa, P.
M. Hoi, K. Chan, S.M. Lee, Danshensu protects against 6-hydroxydopamine-
induced damage of PC12 cells in vitro and dopaminergic neurons in zebraﬁsh,
Neurosci. Lett. 543 (2013) 121–125.
[42] B. Vurusaner, P. Gamba, G. Testa, S. Gargiulo, F. Biasi, C. Zerbinati, L. Iuliano,
G. Leonarduzzi, H. Basaga, G. Poli, Survival signaling elicited by 27-hydro-
xycholesterol through the combined modulation of cellular redox state and
ERK/Akt phosphorylation, Free Radic. Biol. Med. 77 (2014) 376–385.
[43] N. Klonis, S.C. Xie, J.M. McCaw, M.P. Crespo-Ortiz, S.G. Zaloumis, J.A. Simpson,
L. Tilley, Altered temporal response of malaria parasites determines differ-
ential sensitivity to artemisinin, Proc. Natl. Acad. Sci. USA 110 (13) (2013)
5157–5162.
